Inicio>>New Products>>GMax™ Liposome2000 Transfection Reagent

GMax™ Liposome2000 Transfection Reagent (Synonyms: Lipo6000)

Catalog No.GK20005

El Reactivo de Transfección GMax™ Liposome2000 es una formulación exclusiva para transfectar ácidos nucleicos en una amplia variedad de células eucariotas.

Products are for research use only. Not for human use. We do not sell to patients.

GMax™ Liposome2000 Transfection Reagent Chemical Structure

Tamaño Precio Disponibilidad Cantidad
0.75mL
200,00 $
Disponible
1.5mL
360,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 7 publications

Description Protocol Components Product Documents Related Video Related Products

GMax™ Liposome2000 Transfection Reagent is a proprietary formulation for transfecting nucleic acids into a wide range of eukaryotic cells. DNA-GMax™ Liposome2000 complexes must be made in serum-free medium such as Opti-MEM® Reduced Serum Medium and can be added directly to cells in culture medium, in the presence or absence of serum/antibiotic. It is not necessary to remove complexes or change/add medium after transfection. The amount of GMax™ Liposome2000 Reagent required for successful transfection varies depending on the cell type and passage number. Start any new transfection by testing the recommended four concentrations of GMax™ Liposome2000 Reagent to determine an optimum amount.

Reseñas

Review for GMax™ Liposome2000 Transfection Reagent

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GMax™ Liposome2000 Transfection Reagent

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.